These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1011503)

  • 1. [Hormonal disturbances and the treatment of refractory forms of congestive circulatory insufficiency].
    Korochkin IM; Matveeva IV
    Kardiologiia; 1976 Aug; 16(8):36-43. PubMed ID: 1011503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of aldactone-saltucine for patients with chronic circulatory insufficiency].
    Sidorenko BA; Savenkov PM; Kharchenko VI; Evsikov EM
    Kardiologiia; 1975 May; 15(5):108-14. PubMed ID: 1152319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperaldosteronism and the use of aldactone in cardiac insufficiency].
    Korochkin IM; Matveeva IV; Sidorenko BA; Arshakuni RO
    Kardiologiia; 1968 Dec; 8(12):74-81. PubMed ID: 5736746
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of aldactone-saltucine in patients with heart failure].
    Bobkova VI; Kartitskií VS; Lapkes TG; Mazurova SV
    Kardiologiia; 1975 May; 15(5):105-8. PubMed ID: 1152318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE.
    CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC
    Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure.
    Levy B
    J Clin Pharmacol; 1977 Jul; 17(7):420-30. PubMed ID: 328540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the activity of the renin-aldosterone system under the effect of diuretics in patients with circulatory insufficiency].
    Speranskaia NV; Kuz'mina AE
    Kardiologiia; 1972 Feb; 12(2):71-8. PubMed ID: 4635553
    [No Abstract]   [Full Text] [Related]  

  • 8. [Excretion of adrenal hormones in patients with congestive circulatory insufficiency].
    Kukes VG; Men'shikov VV; Bass ZhZh; Shekhter IM; Anastas'ina GV
    Kardiologiia; 1970 Feb; 10(2):72-8. PubMed ID: 5428120
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electrolyte excretion following administration of various diuretics in healthy females].
    Matzkies F; Webs B
    Fortschr Med; 1984 Feb; 102(6):133-7. PubMed ID: 6706271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antiedematous activity of a table salt substitute, veroshpiron and furosemide in experimental circulatory failure].
    Shtrygol' SIu
    Farmakol Toksikol; 1990; 53(4):65-7. PubMed ID: 2226768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.
    Trune DR; Kempton JB; Gross ND
    Hear Res; 2006 Feb; 212(1-2):22-32. PubMed ID: 16307853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of saluretics and spironolactone on aldosterone production and electrolyte excretion in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(2):145-56. PubMed ID: 4281879
    [No Abstract]   [Full Text] [Related]  

  • 13. [The factors that regulate water-salt metabolism in congestive heart failure].
    Marenzi GC; Grazi S; Salvioni A; Lauri G; Perego GB; Guazzi M; Agostoni PG
    Cardiologia; 1993 May; 38(5):287-95. PubMed ID: 8104696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hydroflumethiazide in congestive heart failure: renal electrolyte excretion related to urinary thiazide excretion and aldosterone.
    Brørs O; Enger E; Jacobsen S; Aakvaag A; Foss OP
    Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):399-406. PubMed ID: 7345881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of cardiac patients with furosemide. Effect on hemodynamics, water and electrolyte balance].
    Sidorenko BA
    Munch Med Wochenschr; 1969 Oct; 111(40):2032-7. PubMed ID: 5394863
    [No Abstract]   [Full Text] [Related]  

  • 18. [Distribution of fluid between the cells and the extracellular media and mineralocorticoid function of the adrenal glands in cardiac insufficiency].
    Sycheva IM; Vinogradov AV; Kuz'mina AE; Kiseleva ZM
    Kardiologiia; 1969 Jun; 9(6):19-25. PubMed ID: 4896758
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I; Rabinovitz M; Rosenfeld JB
    Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of furosemide (lasix) in patients with circulatory insufficiency: effect on hemodynamics and water-salt metabolism].
    Sidorenko BA
    Kardiologiia; 1966; 6(5):53-61. PubMed ID: 6000273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.